We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+473.22%
AUM
$422B
AUM Growth
+$16.7B
Cap. Flow
+$3.59B
Cap. Flow %
0.85%
Top 10 Hldgs %
15.94%
Holding
4,365
New
134
Increased
2,592
Reduced
1,225
Closed
95

Sector Composition

Rank Sector Weight
1 Technology 16.89%
2 Financials 14.44%
3 Healthcare 12.64%
4 Consumer Discretionary 10.01%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMO
3551
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$491K ﹤0.01%
36,918
-1,517
-4% -$22.9K
MACK
3552
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$491K ﹤0.01%
103,163
+151
+0.1% +$715
CCRD
3553
DELISTED
CoreCard
CCRD
$490K ﹤0.01%
17,002
+5,582
+49% +$186K
OCSL icon
3554
Oaktree Specialty Lending
OCSL
$1.02B
$490K ﹤0.01%
30,090
-147
-0.5% -$2.38K
AKTS
3555
DELISTED
Akoustis Technologies Inc
AKTS
$490K ﹤0.01%
76,547
+21,087
+38% +$144K
TLND
3556
DELISTED
Talend S.A. American Depositary Shares
TLND
$490K ﹤0.01%
12,693
-27
-0.2% -$1.26K
PHAS
3557
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$486K ﹤0.01%
+37,027
New +$454K
EVFM
3558
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$483K ﹤0.01%
4,847
+2,565
+112% +$199K
MLNT
3559
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$482K ﹤0.01%
72,455
-5,984
-8% -$22.8K
BTAI icon
3560
BioXcel Therapeutics
BTAI
$24.9M
$481K ﹤0.01%
2,739
+1,951
+248% +$330K
APTX
3561
DELISTED
Aptinyx Inc. Common Stock
APTX
$480K ﹤0.01%
143,850
-7,861
-5% -$27.9K
KG
3562
Kestrel Group
KG
$69.4M
$479K ﹤0.01%
37,443
-2,605
-7% -$35.9K
BBCP icon
3563
Concrete Pumping Holdings
BBCP
$490M
$478K ﹤0.01%
+93,313
New +$531K
TPST icon
3564
Tempest Therapeutics
TPST
$13.7M
$477K ﹤0.01%
+212
New +$624K
LFVN icon
3565
LifeVantage
LFVN
$81.1M
$473K ﹤0.01%
36,448
+11,725
+47% +$139K
CHAP
3566
DELISTED
Chaparral Energy, Inc.
CHAP
$473K ﹤0.01%
100,439
+6,236
+7% +$31.2K
IGE icon
3567
iShares North American Natural Resources ETF
IGE
$741M
$472K ﹤0.01%
15,385
-2,500
-14% -$76.4K
SOLY
3568
DELISTED
Soliton, Inc.
SOLY
$472K ﹤0.01%
+32,111
New +$415K
BRID icon
3569
Bridgford Foods
BRID
$57.6M
$470K ﹤0.01%
15,800
+1,571
+11% +$43.2K
BOND icon
3570
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.37B
$469K ﹤0.01%
4,365
-579
-12% -$61.3K
CIX icon
3571
Comp X International
CIX
$349M
$468K ﹤0.01%
27,711
+63
+0.2% +$970
HARP
3572
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$465K ﹤0.01%
3,575
+308
+9% +$35.8K
VDE icon
3573
Vanguard Energy ETF
VDE
$10.1B
$464K ﹤0.01%
5,454
CTIC
3574
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$463K ﹤0.01%
538,290
-29,433
-5% -$27.2K
AXIA
3575
AXIA Energia
AXIA
$23.9B
$462K ﹤0.01%
63,872
+2,509
+4% +$17.1K

Similar funds

Northern Trust's Q2 2019 Portfolio in Review

As of Q2 2019, Northern Trust held 4,365 positions worth $422B, up 4.1% from $405B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Northern Trust's Q2 2019 filing shows 134 new, 2,592 increased, 1,225 reduced and 95 closed positions. Its largest new stake was Dow Inc: 8,733,361 shares worth $431M. The largest sale was DuPont de Nemours, an estimated $404M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Northern Trust's largest Q2 2019 buy was Dow Inc: 8,733,361 shares worth $431M.
  • Northern Trust added most to FlexShares STOXX Global Broad Infrastructure Index Fund in Q2 2019, an estimated $254M increase.
  • Northern Trust's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $404M.
  • Northern Trust fully exited Integrated Device Technology I in Q2 2019, selling an estimated $109M.
  • Northern Trust's ten largest holdings make up 16% of its $422B portfolio in Q2 2019.
  • Northern Trust opened 134 new positions and closed 95 in Q2 2019.
  • Northern Trust's portfolio value rose 4.1% quarter-over-quarter to $422B.

Based on Northern Trust's 13F filing for Q2 2019, filed 13 Aug 2019.